Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ASTELLAS PHARMA A/S
A/S
Active
CVR 10888638
Arne Jacobsens Allé 15, 2300
København S
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1987 · 38 years old
69 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
ASTELLAS PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
55M
110M
165M
220M
160M
2021
180M
2022
181M
2023
187M
2024
191M
2025
EBITDA
DKK millions
11M
8M
6M
3M
0M
5M
2021
9M
+80%
2022
5M
-44%
2023
6M
+20%
2024
6M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
160.457
179.933
180.837
186.855
191.027
Staff expenses
-17.530
-16.971
-17.877
-14.894
-18.559
EBITDA
5.358
9.161
5.224
5.993
5.852
Depreciation & amort.
-170
-147
-126
-61
-60
EBIT
5.188
9.014
5.098
5.932
5.792
Net financials
2.656
125
-2.195
86
1.728
Profit before tax
7.844
9.139
2.903
6.018
7.520
Tax
1.979
2.450
822
1.548
1.815
Net profit
5.865
6.689
2.081
4.470
5.705
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
145.455
345.591
112.042
100.770
109.956
Equity
59.437
58.226
35.307
24.696
20.814
Long-term debt
0
0
0
0
0
Short-term debt
85.972
287.365
76.735
76.057
89.120
Total debt
85.972
287.365
76.735
76.057
89.120
Financial ratios
5-year trend
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
2021
2025
Equity ratio
18.9%
This company
38.2%
Market median
-51% vs market
2021
2025
Return on equity
27.4%
This company
18.4%
Market median
+49% vs market
2021
2025
Net profit margin
3.0%
This company
8.1%
Market median
-63% vs market
2021
2025
Asset turnover
1.74×
This company
1.12×
Market median
+55% vs market
2021
2025
Debt / equity
4.28×
This company
0.62×
Market median
-590% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
View
PDF
More on ASTELLAS PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
